spot_img

Amferia Granted US Patent for its Antimicrobial Material Platform

Date:

Share:

The Swedish medical device company Amferia AB announced today that it has been granted the foundational patent by the United States Patent and Trademark Office (USPTO) for its innovative antimicrobial material based on an amphiphilic antimicrobial hydrogel. The company is now in its final stages of product development for wound care applications and aims to launch the first product within animal health during 2022. The patent (US 11235021) concerns the primary invention behind Amferia’s platform technology, an amphiphilic antimicrobial hydrogel material that can rapidly bind and kill all types of bacteria, even antimicrobial resistant bacteria, on to its surface without harming the body. The material utilizes co-valent binding between antimicrobial peptides and an amphiphilic hydrogel to form a solid antimicrobial hydrogel material, which exerts a strong antibacterial effect upon direct contact with bacteria, without leaching or release of any antimicrobials into the environment around the material. Amferia is today translating this invention into wound care products for both human and animal health. Anand Kumar Rajasekharan, CEO of Amferia − “This is an important milestone as the granted patent recognizes the core invention of Amferia. We are very excited that the patent grant coincides with our recent product development within wound care for the European and US market. Of special relevance to this patent is our ongoing process for seeking US FDA 510k clearance on our wound dressing product.”
 
- Advertisement -spot_img
- Advertisement -spot_img

━ More Like This

PLASTASIA 2027 Gains Traction as Exhibition Bookings Reach 85%

PLASTASIA 2027 Gains Traction as Exhibition Bookings Reach 85% The 9th edition of PLASTASIA, scheduled to take place between 20th and 23rd May, 2027 at...

ENVIA ESSENTIAL Helps Tackle Organic Buildup in Hard-Water Applications

ENVIA ESSENTIAL Helps Tackle Organic Buildup in Hard-Water Applications Bionetix has introduced ENVIA ESSENTIAL, a ready-to-use enzymatic concentrate designed to help food service, food processing,...

ZAHORANSKY to Adjust German Operations, Up to 120 Jobs Impacted

ZAHORANSKY to Adjust German Operations, Up to 120 Jobs Impacted ZAHORANSKY AG is planning further measures to future-proof the ZAHORANSKY Group at its German sites....

Covestro and puren Boost Environmental Performance of purenit®

Covestro and puren Boost Environmental Performance of purenit "With ISCC PLUS certification across our entire purenit® production we have the basis to use Desmodur®...

AZL Deploys JetBlast System for Next-Generation Battery-Enclosure Development

AZL Deploys JetBlast System for Next-Generation Battery-Enclosure Development Validated test system enables reproducible application-specific temperature, flame and hot-particle load profiles – benchmark test campaign starts...